Advertisement
Screener

Perrigo Company plc (PRGO) Preferred Stock, Shares Outstanding

1.3 / 5 stars · 28/110 Roast Me

Perrigo Company plc Preferred Stock, Shares Outstanding

Perrigo Company plc (PRGO) had Preferred Stock, Shares Outstanding of 0 shares as of 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesOutstanding · last filed 2026-08-05

  • 2026-06-27: Preferred Stock, Shares Outstanding 0.00 shares.
  • 2026-03-28: Preferred Stock, Shares Outstanding 0.00 shares.
  • 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
  • 2025-09-27: Preferred Stock, Shares Outstanding 0.00 shares.
Period endPreferred Stock, Shares Outstanding
2026-06-270.00 shares
10-Q · filed 2026-08-05
2026-03-280.00 shares
10-Q · filed 2026-05-06
2025-12-310.00 shares
10-Q · filed 2026-08-05
2025-09-270.00 shares
10-Q · filed 2025-11-05
2025-06-280.00 shares
10-Q · filed 2025-08-06
2025-03-290.00 shares
10-Q · filed 2025-05-07
2024-12-310.00 shares
10-K · filed 2026-02-26
2024-09-280.00 shares
10-Q · filed 2024-11-06
2024-06-290.00 shares
10-Q · filed 2024-08-02
2024-03-300.00 shares
10-Q · filed 2024-05-07
2023-12-310.00 shares
10-K · filed 2025-02-28
2022-12-310.00 shares
10-K · filed 2024-02-27
2016-10-010.00 shares
10-Q · filed 2016-11-10
2016-07-020.00 shares
10-Q · filed 2016-08-10
2016-04-020.00 shares
10-Q · filed 2016-05-16
2015-12-310.00 shares
10-Q · filed 2016-11-10
2015-09-260.00 shares
10-Q · filed 2015-11-02
2015-06-270.00 shares
10-Q · filed 2015-11-02
2015-03-280.00 shares
10-Q · filed 2015-04-29
2014-12-270.00 shares
10-Q · filed 2015-02-05
2014-09-270.00 shares
8-K · filed 2014-11-20
2014-06-280.00 shares
10-Q · filed 2015-04-29
2014-03-290.00 shares
10-Q · filed 2014-05-07
2013-12-280.00 shares
10-Q · filed 2014-02-06
2013-06-290.00 shares
10-Q · filed 2014-05-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38